SUPPORT AGREEMENTSupport Agreement • November 1st, 2016 • Signal Genetics, Inc. • Services-medical laboratories • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of October 31, 2016, is by and among Miragen Therapeutics, Inc. (“Miragen”), and the Person set forth on Schedule A hereto (the “Stockholder”).
SIGNAL GENETICS, INC. AMENDMENT TO UNSECURED DEMAND PROMISSORY NOTESignal Genetics, Inc. • November 1st, 2016 • Services-medical laboratories • Delaware
THIS AMENDMENT TO UNSECURED DEMAND PROMISSORY NOTE (this “Amendment”) is made and entered into as of October 31, 2016 (the “Effective Date”) by and between Signal Genetics, Inc., a Delaware corporation (“Payor”), and Bennett LeBow, the holder (“Holder”) of that certain Unsecured Demand Promissory Note dated as of March 6, 2015 (the “Note”).
